Carol M. Moinpour

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013”.

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Journal of Patient-Reported Outcomes(2020)10.1186/s41687-020-00220-x

N/A

0DataRank · unranked

5 citations

Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries +15 more

The challenge of measuring intra-individual change in fatigue during cancer treatment

UNC Libraries(2020)10.17615/c7jf-hg10

N/A

0DataRank · unranked

0 citations

Anthony L. Back, Deena R. Loeffler, Jimmy Hwang, Nan Rothrock, Bryce B. Reeve +12 more

Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients

UNC Libraries(2020)10.17615/c4qx-4c05

N/A

0DataRank · unranked

0 citations

Lisa E. Paddock, Ashley Wilder Smith, Theresa H.M. Keegan, Arnold L. Potosky, Elizabeth A. Hahn +6 more

Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad003

N/A

0DataRank · unranked

8 citations

Qian Lu, Mary W. Redman, Susan S. Tavernier, Lori M. Minasian, Ellen V. Sigal +17 more